Nunzia Pharmaceutical Corporation through its Medical Supply division, is offering the patented Blood Warmer. Nunzia has the exclusive license to sell the IV BLOOD WARMING SYSTEM that is adaptable to handle many of the procedures that are performed in the medical field for the prevention of hypothermia. Medical research has shown that there is a large and growing need for a small, portable fluid warmer to combat the occurrence of hypothermia in the medical and paramedical fields. Recognizing this critical need. The IV Fluid Warmer is a portable, reusable 110V, AC-powered IV warmer product that will preheat intravenous solutions at the point of infusion. It has an output temperature range of 37°C to 41°C. The system shuts off automatically at 44°C to prevent overheating of the unit. The fluid warmer contains a disposable cartridge that can be recycled or returned for disposal. The device is UL and FDA approved and PATENT No.6,788,885 B2, The global blood fluid warming system market is expected to witness significant growth during the forecast period. The market is driven by growing demand for blood fluid warming systems due to rise in hypothermia cases. Hypothermia prevails more in cold regions and is more commonly found in geriatric and infant population. Additionally, an increase in surgical procedures along with an aging population is the biggest factor propelling the market growth. NUNZIA is currently available as a nutraceutical supplement, with prescribed and over-the-counter pharmaceutical treatments planned, and is unique within this space as a positive treatment quite unlike other drugs and supplements on the market. With no known negative side effects, no known addictions, and no clinical reaction to alcohol -- NUNZIA is one of the safest treatments on the market with no known adverse effects on vital organs. NUNZIA nutraceuticals are a patented combination of 16 vitamins, minerals, and herbs which directly focus and target the hippocampus area of the brain, where all anxiety-based disorders begin NUNZIA directly targets anxiety in the hippocampus, improving the function, which is a primary cause of the affiliations and compulsory disorders present in ASDs and anxiety disorders. Treatment The NUNZIA supplement with NUNZIA has demonstrated positive results for affected patients, increased memory, improved fine motor skills and increased speech ability while decreasing the anxiety, stress, fixations, and fidgeting that complicates social interactions and life with ASDs and other anxiety disorders.